DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Neurocrine Biosciences, Inc. (NBIX)
« Back to company indexNBIX Chatter Timeline
Stock Ticker for NBIX
Most Active Tweeters for NBIX
| User | Tweets |
|---|---|
| @ChartMill | 5 |
| @VisualStockRSRC | 4 |
| @AmericanBanking | 4 |
| @TickerReport | 4 |
| @confcalltran | 3 |
Recent Tweets for NBIX
 |
@TickerReport Zacks: Analysts Expect Neurocrine Biosciences, Inc. $NBIX Will Post Quarterly Sales of $211.30 Million https://t.co/FZfoVca1FW 10:09am |
|
@TickerReport $0.67 EPS Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/0gtU8IlKlT 10:09am |
 |
@dispatchtribune $211.30 Million in Sales Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/8L5IjseKpE 10:09am |
|
@TickerReport Neurocrine Biosciences $NBIX Lowered to “Hold” at BidaskClub https://t.co/i6mMB5fz73 6:09am |
 |
@ChartMill In the last month $NBIX has a been trading in the 92.44 - 101.01 range, which is quite wide. https://t.co/Cm7bbbnXrW https://t.co/W66pAZFr8H September 15th 2019, 10:09pm |
|
@ChartMill Good technicals, but also a nice setup pattern forming for $NBIX. Now part of our top breakout selection. https://t.co/RZeXihazGH September 15th 2019, 3:09pm |
 |
@stocknewstimes Neurocrine Biosciences $NBIX Downgraded to Hold at BidaskClub https://t.co/xLprt7oyDL September 14th 2019, 3:09pm |
 |
@TranscriptDaily BidaskClub Downgrades Neurocrine Biosciences $NBIX to Hold https://t.co/V657lk7Mzv September 14th 2019, 3:09pm |
 |
@NewZombie99 $NBIX One of the old favs from biotech land coming back in focus after bounce from 50 MA on daily. 21 EMA cross nex… https://t.co/FZoJAoGoAx September 14th 2019, 2:09pm |
 |
@sssvenky Watching $AJRD and $NBIX on daily - sideways consolidation so far. September 14th 2019, 11:09am |
|
@ChartMill A very nice breakout setup pattern for $NBIX, will it break out? https://t.co/4F9NyNNwWP September 14th 2019, 12:09am |
|
@ChartMill $NBIX showing up in our top Strong Growth selection and may be ready for breakout. https://t.co/4F9NyNNwWP September 13th 2019, 10:09am |
 |
@confcalltran Neurocrine Biosciences director was just granted 15,000 options https://t.co/2twIic1DJv $NBIX September 12th 2019, 4:09pm |
 |
@VisualStockRSRC $NBIX - Statement of Changes in Beneficial Ownership (4) https://t.co/ZNDPs6DjAm September 12th 2019, 4:09pm |
|
@confcalltran Neurocrine Biosciences director just declared ownership of no shares of Neurocrine Biosciences https://t.co/2OuKJfbMH9 $NBIX September 12th 2019, 4:09pm |
|
@VisualStockRSRC $NBIX - Initial Statement of Beneficial Ownership (3) https://t.co/rux4R2JfaU September 12th 2019, 4:09pm |
|
@ChartMill $NBIX is growing strongly and shows a nice technical setup now! https://t.co/aCamqLEUON September 12th 2019, 1:09pm |
 |
@HottestStockNow $NBIX Makes Strategic Move #Neurocrine https://t.co/YYpMqtrcmR September 11th 2019, 6:09pm |
|
@confcalltran Current report, item 5.02 https://t.co/1jX6tPAmF7 $NBIX September 11th 2019, 5:09pm |
 |
@Stock_News_Now $NBIX: New SEC Filing for NBIX: Form 8-K (No. 0001564590-19-034520): https://t.co/374K6fw6zv September 11th 2019, 4:09pm |
 |
@StockTexts $NBIX Neurocrine Biosciences, Inc. SEC Filing: Form 8-K https://t.co/PYsHSnVsNw September 11th 2019, 4:09pm |
|
@VisualStockRSRC $NBIX - Current Report Filing (8-k) https://t.co/KNO0HBox2e September 11th 2019, 4:09pm |
 |
@Jdalexander64 @tribui So if $ACAD $NBIX so inefficiently prices yet have big volume, why are they not efficiently valued? Should… https://t.co/uQjOGK0iM7 September 11th 2019, 4:09pm |
 |
@ProTradersNews $NBIX: Neurocrine Biosciences Announces Appointment of Leslie V …: https://t.co/uUzle4lOdH September 11th 2019, 4:09pm |
|
@VisualStockRSRC $NBIX - Neurocrine Biosciences Announces Appointment of Leslie V. Norwalk to Board of Directors https://t.co/9nK9rYW2Ax September 11th 2019, 4:09pm |
 |
@SeekingAlpha $NBIX - Neurocrine Biosciences (NBIX) Presents At Baird Global Healthcare Conference - Slideshow https://t.co/g3AzunWe9X September 11th 2019, 11:09am |
 |
@Gambiste1 RT @SheffStation: $NBIX..$94.65..Survey Suggests That Recent Awareness Efforts Are Starting To Pay Off. Their survey of psychs, feedback su… September 11th 2019, 3:09am |
 |
@AmericanBanking Zacks: Analysts Expect Neurocrine Biosciences, Inc. $NBIX Will Post Quarterly Sales of $211.30 Million https://t.co/z6rA3cvjbD #stocks September 11th 2019, 1:09am |
|
@TickerReport Traders Buy Large Volume of Put Options on Neurocrine Biosciences $NBIX https://t.co/vyqSwEXDbb September 11th 2019, 1:09am |
 |
@ZolmaxNews Neurocrine Biosciences, Inc. $NBIX Receives $105.50 Average PT from Brokerages https://t.co/b7JXGFOZjm September 10th 2019, 2:09pm |
 |
@dailypoliticaln Analysts Set Neurocrine Biosciences, Inc. $NBIX PT at $105.50 https://t.co/u91BVEUCfH September 10th 2019, 1:09pm |
 |
@SheffStation $NBIX..$94.65..Survey Suggests That Recent Awareness Efforts Are Starting To Pay Off. Their survey of psychs, feedb… https://t.co/rY0NUsAwDu September 10th 2019, 1:09pm |
 |
@happyycamperr $NBIX....another Hidey Hole gets a hand grenade....lol September 10th 2019, 11:09am |
 |
@avidresearch $NBIX ?? September 10th 2019, 11:09am |
 |
@BioWino $nbix $vrtx completely normal September 10th 2019, 11:09am |
 |
@sunrgu $NBIX resin for sell off? September 10th 2019, 10:09am |
|
@AmericanBanking Investors Buy Large Volume of Neurocrine Biosciences Put Options $NBIX https://t.co/pO5ChmY4ZX #stocks September 10th 2019, 8:09am |
 |
@bbnsnews Neurocrine Biosciences, Inc. $NBIX Expected to Post Earnings of $0.67 Per Share https://t.co/HbC6V2K2W0 September 9th 2019, 10:09pm |
|
@AmericanBanking Neurocrine Biosciences, Inc. $NBIX Expected to Post Earnings of $0.67 Per Share https://t.co/slHZ4ecrZX #stocks September 9th 2019, 10:09pm |
 |
@MC_OptionTrades $NBIX 20-Sep-19 Straddle Implies a ±4.8% move. Sep 10 Morgan Stanley 17th Annual Healthcare Conference https://t.co/qDMpSzVjEf September 9th 2019, 9:09pm |
|
@AmericanBanking Royal Bank of Canada Analysts Give Neurocrine Biosciences $NBIX a $118.00 Price Target https://t.co/IK5vL0XmQ6 #stocks September 9th 2019, 12:09am |
 |
@ThisLincolnian Neurocrine Biosciences $NBIX Given a $118.00 Price Target at Royal Bank of Canada https://t.co/05iMQxkiAz September 9th 2019, 12:09am |
|
@dispatchtribune Neurocrine Biosciences $NBIX Given a $118.00 Price Target at Royal Bank of Canada https://t.co/Y3h2gAlPXh September 9th 2019, 12:09am |
 |
@WeekHerald Neurocrine Biosciences $NBIX Given a $118.00 Price Target at Royal Bank of Canada https://t.co/hR32BtoIzo September 9th 2019, 12:09am |
 |
@OlympiaReport Neurocrine Biosciences $NBIX Given a $118.00 Price Target at Royal Bank of Canada https://t.co/yoNa0JL14z September 9th 2019, 12:09am |
|
@bbnsnews Neurocrine Biosciences $NBIX PT Set at $118.00 by Royal Bank of Canada https://t.co/aOIGAguYbQ September 8th 2019, 11:09pm |
|
@bbnsnews Neurocrine Biosciences, Inc. $NBIX Insider Sells $673,600.00 in Stock https://t.co/tI9kyYSYRf September 7th 2019, 1:09pm |
 |
@PLHstock $NBIX sure looking like it wants to bust out over that $100 level. One of several names on our free weekly watch l… https://t.co/ImEq5wPnnD September 7th 2019, 1:09pm |
|
@TranscriptDaily Neurocrine Biosciences $NBIX Upgraded at BidaskClub https://t.co/b0TjODTfND August 11th 2019, 6:08pm |
|
@TickerReport Neurocrine Biosciences $NBIX Now Covered by Royal Bank of Canada https://t.co/Ryjo5JvQ7O August 11th 2019, 1:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.